CLSA is supportive of pending legislation to renew Trade Promotion Authority (TPA), which contains a number of provisions that would allow the Administration to better protect IP rights and fair market access when negotiating trade deals.
CLSA strongly supports a full repeal of the medical device tax, and is urging members of the California congressional delegation to vote in support of H.R. 160, the Protect Medical Innovation Act, when it is brought to the full House for a vote as early as the week of June 15.
Rep. Suzan DelBene, Rep. Kyrsten Sinema and Rep. Scott Peters pen an op-ed in The Huffington Post on the need to repeal the medical device tax. Doing so would stimulate our economy, strengthen America’s global leadership, and invest in a brighter tomorrow.
Ron Leuty of the San Francisco Business Times conducts a profile on CLSA’s mission, goals and incoming President & CEO Sara Radcliffe, as part of the publications annual biotech section.
CLSA featured in San Diego Business Journal article on the need to increase H1-B Visa’s to foster a greater ability for life sciences to compete globally.
Smart, connected medical devices are now technologically and economically feasible. A new report from Deloitte Center for Health Solutions looks how an increasingly intelligent future will reshape the MedTech industry.
The 21st Century Cures Act is not only visionary, but critical to ensuring that California and our nation remains the worldwide leader in life sciences research, investment and innovation.
Landmark legislation will modernize biomedical discovery, development and delivery to bring new therapies and cures to patients.
CLSA is committed to providing one robust, unified voice for California’s statewide life sciences sector, which works tirelessly to drive transformative innovation that will benefit patients and consumers in the U.S. and around the world for years to come.
BioSpace.com article on CLSA discusses the merger of CHI & BayBio, making California Life Sciences Association the Largest Life Sciences Advocacy Group in U.S.